These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30757963)

  • 1. Analyzing pre-post designs using the analysis of covariance models with and without the interaction term in a heterogeneous study population.
    Wan F
    Stat Methods Med Res; 2020 Jan; 29(1):189-204. PubMed ID: 30757963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyzing pre-post randomized studies with one post-randomization score using repeated measures and ANCOVA models.
    Wan F
    Stat Methods Med Res; 2019; 28(10-11):2952-2974. PubMed ID: 30084297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of covariance with pre-treatment measurements in randomized trials under the cases that covariances and post-treatment variances differ between groups.
    Funatogawa T; Funatogawa I; Shyr Y
    Biom J; 2011 May; 53(3):512-24. PubMed ID: 22223254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical analysis of two arm randomized pre-post designs with one post-treatment measurement.
    Wan F
    BMC Med Res Methodol; 2021 Jul; 21(1):150. PubMed ID: 34303343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of covariance with pre-treatment measurements in randomized trials: comparison of equal and unequal slopes.
    Funatogawa I; Funatogawa T
    Biom J; 2011 Sep; 53(5):810-21. PubMed ID: 21887795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bias, precision and statistical power of analysis of covariance in the analysis of randomized trials with baseline imbalance: a simulation study.
    Egbewale BE; Lewis M; Sim J
    BMC Med Res Methodol; 2014 Apr; 14():49. PubMed ID: 24712304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robustness of ANCOVA in randomized trials with unequal randomization.
    Bartlett JW
    Biometrics; 2020 Sep; 76(3):1036-1038. PubMed ID: 31823345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized clinical trials with a pre- and a post-treatment measurement: repeated measures versus ANCOVA models.
    Winkens B; van Breukelen GJ; Schouten HJ; Berger MP
    Contemp Clin Trials; 2007 Nov; 28(6):713-9. PubMed ID: 17524958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal analysis of pre- and post-treatment measurements with equal baseline assumptions in randomized trials.
    Funatogawa I; Funatogawa T
    Biom J; 2020 Mar; 62(2):350-360. PubMed ID: 31394012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression analysis for covariate-adaptive randomization: A robust and efficient inference perspective.
    Ma W; Tu F; Liu H
    Stat Med; 2022 Dec; 41(29):5645-5661. PubMed ID: 36134688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of covariance in parallel-group clinical trials with pretreatment baselines.
    Crager MR
    Biometrics; 1987 Dec; 43(4):895-901. PubMed ID: 3427174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of covariance in randomized trials: More precision and valid confidence intervals, without model assumptions.
    Wang B; Ogburn EL; Rosenblum M
    Biometrics; 2019 Dec; 75(4):1391-1400. PubMed ID: 31009064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact Evaluation Using Analysis of Covariance With Error-Prone Covariates That Violate Surrogacy.
    Lockwood JR; McCaffrey DF
    Eval Rev; 2019 Dec; 43(6):335-369. PubMed ID: 31578089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data.
    Vickers AJ
    BMC Med Res Methodol; 2005 Nov; 5():35. PubMed ID: 16269081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient: a simulation study.
    Vickers AJ
    BMC Med Res Methodol; 2001; 1():6. PubMed ID: 11459516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using analysis of covariance (ANCOVA) with fallible covariates.
    Culpepper SA; Aguinis H
    Psychol Methods; 2011 Jun; 16(2):166-78. PubMed ID: 21517178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The optimal pre-post allocation for randomized clinical trials.
    Ma S; Wang T
    BMC Med Res Methodol; 2023 Mar; 23(1):72. PubMed ID: 36978004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline corrections in experimental and quasi-experimental clinical trials.
    Overall JE; Ashby B
    Neuropsychopharmacology; 1991 Jun; 4(4):273-81. PubMed ID: 1867736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A readily available improvement over method of moments for intra-cluster correlation estimation in the context of cluster randomized trials and fitting a GEE-type marginal model for binary outcomes.
    Westgate PM
    Clin Trials; 2019 Feb; 16(1):41-51. PubMed ID: 30295512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing unequal randomization in clinical trials with heterogeneous treatment costs.
    Sverdlov O; Ryeznik Y
    Stat Med; 2019 Jul; 38(16):2905-2927. PubMed ID: 31049999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.